These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7464500)

  • 1. [Current treatment of Parkinsonian syndrome].
    Lechner H; Bertha G; Ott E
    Med Welt; 1980 Oct; 31(40):1444-6. PubMed ID: 7464500
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of parkinsonian syndromes by bromocriptin].
    Gautier JC; Durand JP
    Nouv Presse Med; 1977 Jan; 6(3):171-4. PubMed ID: 319421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current medical treatment of Parkinsonian syndromes].
    Cincă I; Bulandra R; Serbănesco A; Ninosu N
    Rev Roum Neurol; 1973; 10(4):257-85. PubMed ID: 4767886
    [No Abstract]   [Full Text] [Related]  

  • 4. [Revision of the treatment strategy in Parkinson disease].
    Staal-Schreinemachers AL; Wesseling H; Lakke JP
    Ned Tijdschr Geneeskd; 1986 May; 130(20):914-8. PubMed ID: 3724865
    [No Abstract]   [Full Text] [Related]  

  • 5. [Current treatment of the Parkinsonian syndrome].
    Voiculescu V
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1985; 30(3):161-6. PubMed ID: 2868512
    [No Abstract]   [Full Text] [Related]  

  • 6. [Useful data on parkinsonian syndromes].
    Espadaler Medina JM
    Med Clin (Barc); 1985 May; 84(20):828-33. PubMed ID: 4033265
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of Parkinson syndrome].
    Clarenbach P; Fröscher W
    Fortschr Med; 1986 Nov; 104(44):857-61. PubMed ID: 3804157
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antiparkinson agents].
    Staal-Schreinemachers AL; Lakke JP
    Ned Tijdschr Geneeskd; 1987 Feb; 131(6):228-30. PubMed ID: 3561558
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug management of Parkinson's disease.
    Kishore A; Snow BJ
    Can Fam Physician; 1996 May; 42():946-52. PubMed ID: 8688697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinsonism from methanol poisoning: benefit from treatment with anti-Parkinson drugs.
    Davis LE; Adair JC
    Mov Disord; 1999 May; 14(3):520-2. PubMed ID: 10348484
    [No Abstract]   [Full Text] [Related]  

  • 11. [Crises in the course of Parkinson's disease].
    Danielczyk W
    Wien Med Wochenschr; 1980 Feb; 130(4):149-51. PubMed ID: 7376682
    [No Abstract]   [Full Text] [Related]  

  • 12. Parkinson's disease.
    Barboi AC; Goetz CG
    Clin Neuropharmacol; 1999; 22(4):184-91. PubMed ID: 10442246
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental and clinical studies on bromocriptine in the Parkinsonian syndrome.
    Goldstein M; Lieberman A; Battista AF; Lew JY; Matsumoto Y
    Acta Endocrinol Suppl (Copenh); 1978; 216():57-66. PubMed ID: 206089
    [No Abstract]   [Full Text] [Related]  

  • 14. [Neurochemical aspects of Parkinson tremor].
    Agostini L; Firenze C; Gallai V; Piccinin GL; Piccirilli M; Rossi A
    Clin Ter; 1979 Apr; 89(2):119-25. PubMed ID: 487712
    [No Abstract]   [Full Text] [Related]  

  • 15. Update on Parkinson disease.
    Lieberman AN
    N Y State J Med; 1987 Mar; 87(3):147-53. PubMed ID: 3472111
    [No Abstract]   [Full Text] [Related]  

  • 16. Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeys.
    Blanchet PJ; Konitsiotis S; Chase TN
    Mov Disord; 1998 Sep; 13(5):798-802. PubMed ID: 9756148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-dopa responsive parkinsonism secondary to a subdural haematoma.
    Ellul MA; Cross J; Barker RA
    J Clin Neurosci; 2013 Jul; 20(7):1022-4. PubMed ID: 23618681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experience with the use of midantan for treatment and prevention of the neuroleptic syndrome].
    Kamianov IM; Kupisk AG; Katsen IZ
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(8):1218-23. PubMed ID: 4149581
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemiparkinsonism. A human model for studying dopaminergic supersensitivity.
    Trabucchi M; Albizzati MG; Frattola L; Scarlato G
    Arch Neurol; 1979 Apr; 36(4):246-8. PubMed ID: 426672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress in therapy of Parkinsonian syndrome].
    Völler GW
    Hippokrates; 1975 Feb; 46(1):17-33. PubMed ID: 1091605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.